OnKure Therapeutics, Inc. - OKUR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Chief Financial Officer | S | D | 303.0 | 4.3963 | 1,332.08 | 18,802.0 | View | |
| Jun 24, 2026 | President and CEO | S | D | 86.0 | 4.3963 | 378.08 | 11,247.0 | View | |
| Jun 08, 2026 | — | A | A | 1,275.0 | 0.0 | 0.0 | 1,275.0 | View | |
| Jun 08, 2026 | — | A | A | 7,650.0 | 0.0 | 0.0 | 7,650.0 | View | |
| Jun 08, 2026 | — | A | A | 7,650.0 | 0.0 | 0.0 | 7,650.0 | View | |
| Jun 08, 2026 | — | A | A | 7,650.0 | 0.0 | 0.0 | 7,650.0 | View | |
| Jun 08, 2026 | — | A | A | 7,650.0 | 0.0 | 0.0 | 7,650.0 | View | |
| Jun 08, 2026 | — | A | A | 7,650.0 | 0.0 | 0.0 | 7,650.0 | View | |
| Apr 03, 2026 | Chief Medical Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | Chief Scientific Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | Chief Financial Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Apr 03, 2026 | President and CEO | A | A | 330,000.0 | 0.0 | 0.0 | 330,000.0 | View | |
| Apr 01, 2026 | — | A | A | 15,300.0 | 0.0 | 0.0 | 15,300.0 | View | |
| Mar 24, 2026 | Chief Financial Officer | S | D | 301.0 | 4.1565 | 1,251.11 | 16,000.0 | View | |
| Mar 24, 2026 | President and CEO | S | D | 86.0 | 4.1565 | 357.46 | 7,333.0 | View |